Shares of Tenet Healthcare (THC) plummeted 5.02% in Tuesday's trading session, despite the company reporting better-than-expected second-quarter results and raising its full-year 2025 guidance. The sharp decline came as a surprise to many investors, given the seemingly positive news.

Tenet announced Q2 adjusted earnings of $4.02 per share, significantly beating the analyst consensus estimate of $2.87. This represents a 74% increase from the $2.31 per share reported in the same quarter last year. Net operating revenue for the quarter rose 3.3% year-over-year to $5.27 billion, also surpassing analysts' expectations of $5.16 billion.

In light of the strong performance, Tenet raised its full-year 2025 outlook. The company now expects adjusted earnings of $15.55 to $16.21 per share, up from its previous forecast of $11.99 to $13.12. Revenue guidance was also increased to a range of $20.95 billion to $21.25 billion. Despite these positive developments, investors seemed to focus on other factors, potentially including profit-taking after the stock's 38.4% year-to-date gain prior to the earnings release. Additionally, some analysts may be concerned about the sustainability of the company's growth or potential headwinds in the healthcare sector. The unexpected stock drop highlights the complex nature of market reactions to earnings reports, where beating estimates doesn't always guarantee a positive stock movement.